ClinicalTrials.govpublic full text
Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis
multiple sclerosis, relapsing forms of multiple sclerosis, gnbac1, human endogenous retrovirus type w, herv-w, temelimab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801703
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.